Short-Term Effects of Adding Topical Ketorolac to Intravitreal Bevacizumab in Diabetic Macular Edema: A Crossover Randomized Clinical Trial.

Alireza RamezaniHossein MolazemMorteza EntezariHomayoun NikkhahM D Saman RezanejadMehdi Yaseri

Published in: Journal of ophthalmic & vision research (2024)

This crossover clinical trial demonstrated that in the course of DME treatment with IVB injections, topical ketorolac did not have any additive beneficial effect at least during a six-week period.

Keyphrases

double blind
clinical trial
placebo controlled
open label
phase ii
phase iii
study protocol
diabetic retinopathy
combination therapy
metastatic colorectal cancer